บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Jens U. Marquardtดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 12
Functional and genetic deconstruction of the cellular origin in liver cancer
JU Marquardt, JB Andersen, SS Thorgeirsson
Nature Reviews Cancer 15 (11), 653-667, 2015
ข้อกำหนด: US National Institutes of Health, German Research Foundation, Volkswagen …
Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia
I Gockel, J Becker, MM Wouters, S Niebisch, HR Gockel, T Hess, ...
Nature genetics 46 (8), 901-904, 2014
ข้อกำหนด: Research Foundation (Flanders), German Research Foundation
The role of molecular enrichment on future therapies in hepatocellular carcinoma
JC Nault, PR Galle, JU Marquardt
Journal of hepatology 69 (1), 237-247, 2018
ข้อกำหนด: German Research Foundation, Volkswagen Foundation
Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification
D Castven, D Becker, C Czauderna, D Wilhelm, JB Andersen, S Strand, ...
International journal of cancer 144 (11), 2782-2794, 2019
ข้อกำหนด: German Research Foundation, Volkswagen Foundation
Mitochondrial BAX determines the predisposition to apoptosis in human AML
F Reichenbach, C Wiedenmann, E Schalk, D Becker, K Funk, ...
Clinical Cancer Research 23 (16), 4805-4816, 2017
ข้อกำหนด: German Research Foundation, Volkswagen Foundation
Identification of RARRES1 as a core regulator in liver fibrosis
A Teufel, D Becker, SN Weber, S Dooley, K Breitkopf-Heinlein, T Maass, ...
Journal of molecular medicine 90, 1439-1447, 2012
ข้อกำหนด: German Research Foundation
GDF11 restricts aberrant lipogenesis and changes in mitochondrial structure and function in human hepatocellular carcinoma cells
S Hernandez, A Simoni‐Nieves, M Gerardo‐Ramírez, S Torres, R Fucho, ...
Journal of Cellular Physiology 236 (5), 4076-4090, 2021
ข้อกำหนด: US National Institutes of Health, European Commission, Government of Spain
Redox regulation by HGF/c-Met in liver disease
LE Gómez-Quiroz, MC Gutiérrez-Ruiz, JU Marquardt, VM Factor, ...
Liver Pathophysiology, 375-387, 2017
ข้อกำหนด: US National Institutes of Health, Volkswagen Foundation
Ribavirin improves NK cell IFNγ response during sofosbuvir-based DAA therapy in HCV-infected liver transplant recipients
A Adenugba, M Hornung, K Weigand, G Peschel, H Junger, P Kupke, ...
Transplantation 105 (10), 2226-2238, 2021
ข้อกำหนด: German Research Foundation
Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance
D Castven, C Czauderna, JU Marquardt
Resistance to Molecular Therapies for Hepatocellular Carcinoma, 65-91, 2017
ข้อกำหนด: German Research Foundation, Volkswagen Foundation
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis
S Buch, M Krawczyk, M Casper, F Lammert, F Eyer, A Vogel, S Marhenke, ...
ข้อกำหนด: Swiss National Science Foundation, German Research Foundation, Cancer …
Nutrition,(cancer-) stem cells and cancer prevention
FL Mahn, S Franck, C Czauderna, JU Marquardt
ข้อกำหนด: German Research Foundation, Volkswagen Foundation
มีให้ใช้งานในบางที่: 86
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer
JU Marquardt, L Gomez-Quiroz, LOA Camacho, F Pinna, YH Lee, ...
Journal of hepatology 63 (3), 661-669, 2015
ข้อกำหนด: US National Institutes of Health, German Research Foundation
Hepatocyte growth factor/c‐met signaling is required for stem‐cell–mediated liver regeneration in mice
T Ishikawa, VM Factor, JU Marquardt, C Raggi, D Seo, M Kitade, ...
Hepatology 55 (4), 1215-1226, 2012
ข้อกำหนด: US National Institutes of Health
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types
Á Holczbauer, VM Factor, JB Andersen, JU Marquardt, DE Kleiner, ...
Gastroenterology 145 (1), 221-231, 2013
ข้อกำหนด: US National Institutes of Health
Sirtuin‐6–dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients
JU Marquardt, K Fischer, K Baus, A Kashyap, S Ma, M Krupp, M Linke, ...
Hepatology 58 (3), 1054-1064, 2013
ข้อกำหนด: US National Institutes of Health
Induction of chromosome instability by activation of yes-associated protein and forkhead box M1 in liver cancer
SME Weiler, F Pinna, T Wolf, T Lutz, A Geldiyev, C Sticht, M Knaub, ...
Gastroenterology 152 (8), 2037-2051. e22, 2017
ข้อกำหนด: Volkswagen Foundation
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications
JU Marquardt, VM Factor, SS Thorgeirsson
Journal of hepatology 53 (3), 568-577, 2010
ข้อกำหนด: US National Institutes of Health
Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling
M Kitade, VM Factor, JB Andersen, A Tomokuni, K Kaji, H Akita, ...
Genes & development 27 (15), 1706-1717, 2013
ข้อกำหนด: US National Institutes of Health
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer
JB Andersen, VM Factor, JU Marquardt, C Raggi, YH Lee, D Seo, ...
Science translational medicine 2 (54), 54ra77-54ra77, 2010
ข้อกำหนด: US National Institutes of Health
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ